Christopher Trethewey

3PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 18, 2026
A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial.

|Dec 22, 2025
Phased Variant-Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study.

Joanna A Krupka, Ilias Moutsopoulos, Natasha H Cutmore

Pageof 1

Frequent Collaborators

2 joint publications

Caroline M Cowley

2 joint publications

Christopher P Fox

2 joint publications

Matthew J Ahearne

1 joint publications

Ross A Jackson